Endothelial cell hypertrophy induced by vascular endothelial growth factor in the retina: new insights into the pathogenesis of capillary nonperfusion.

OBJECTIVE To investigate the mechanism leading to capillary nonperfusion of the retina in a monkey model of vascular endothelial growth factor A (VEGF)-induced retinopathy in which capillary closure occurs in a late stage after VEGF treatment. METHODS Two monkeys received 4 intravitreous injections of 0.5 microg of VEGF in one eye and of phosphate-buffered saline in the other eye and were killed at day 9. After perfusion and enucleation, retinal samples were snap frozen for immunohistochemical analysis with the panendothelial cell marker CD31 or were fixed for morphometric analysis at the light and electron microscopic level. RESULTS At the light microscopic level, all capillaries in the retina of VEGF-injected eyes displayed hypertrophic walls with narrow lumina. In a quantitative analysis of the deep capillary plexus in the inner nuclear layer, VEGF-injected eyes had a significant 5- to 7-fold decrease in total capillary luminal volume. CD31 staining showed that this decrease was not accompanied by a change in the number of capillaries. Electron microscopy revealed that the luminal volume of individual capillaries of the inner nuclear layer of VEGF-injected eyes was significantly decreased due to a 2-fold hypertrophy of the endothelial cells. CONCLUSIONS Luminal narrowing caused by endothelial cell hypertrophy occurs in the deep retinal capillary plexus in VEGF-induced retinopathy in monkeys. This suggests a causal role of endothelial cell hypertrophy in the pathogenesis of VEGF-induced retinal capillary closure. A similar mechanism may operate in retinal conditions in humans associated with ischemia and VEGF overexpression. CLINICAL RELEVANCE Capillary nonperfusion occurs in diabetic retinopathy and other ischemic diseases associated with overexpression of VEGF. In addition, VEGF-induced endothelial cell hypertrophy may be causative for capillary closure in these diseases.

[1]  D. Hatchell,et al.  Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy. , 1997, The American journal of the medical sciences.

[2]  R. Folberg,et al.  Vascular endothelial growth factor upregulation in human central retinal vein occlusion. , 1998, Ophthalmology.

[3]  L. Aiello,et al.  Clinical implications of vascular growth factors in proliferative retinopathies. , 1997, Current opinion in ophthalmology.

[4]  M. Lagarde,et al.  Involvement of cell-cell interactions in the pathogenesis of diabetic retinopathy. , 1997, Diabetes & metabolism.

[5]  K. Miyarnoto.  Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition , 1999 .

[6]  A. Vortmeyer,et al.  VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. , 1999, Archives of ophthalmology.

[7]  D. Lefer,et al.  Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. , 1995, The American journal of pathology.

[8]  H. Schmid-schönbein,et al.  Red-cell aggregation and red-cell deformability in diabetes. , 1976, Diabetes.

[9]  E. Kohner,et al.  Vascular abnormalities in diabetes and their treatment. , 1980, Transactions of the ophthalmological societies of the United Kingdom.

[10]  G. Lutty,et al.  Localization of vascular endothelial growth factor in human retina and choroid. , 1996, Archives of ophthalmology.

[11]  K Miyamoto,et al.  VEGF increases retinal vascular ICAM-1 expression in vivo. , 1999, Investigative ophthalmology & visual science.

[12]  G. Schmid-Schönbein,et al.  Mechanisms and consequences of cell activation in the microcirculation. , 1996, Cardiovascular research.

[13]  G. Schmid-Schönbein,et al.  Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.

[14]  S. Bursell,et al.  Vascular endothelial growth factor and severity of nonproliferative diabetic retinopathy mediate retinal hemodynamics in vivo: a potential role for vascular endothelial growth factor in the progression of nonproliferative diabetic retinopathy. , 1997, American journal of ophthalmology.

[15]  M. J.,et al.  Diabetic Microangiopathy , 2017 .

[16]  E. Weibel.  Practical methods for biological morphometry , 1979 .

[17]  Joan W. Miller,et al.  Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.

[18]  V. V. van Hinsbergh,et al.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease , 1997, The British journal of ophthalmology.

[19]  E. Keshet,et al.  Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[20]  C Michiels,et al.  Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. , 1993, The American journal of physiology.

[21]  B. Brenner,et al.  Pathogenesis of diabetic microangiopathy. The hemodynamic view. , 1986, The American journal of medicine.

[22]  E M Kohner,et al.  Role of Blood Flow and Impaired Autoregulation in the Pathogenesis of Diabetic Retinopathy , 1995, Diabetes.

[23]  R. Frank,et al.  On the pathogenesis of diabetic retinopathy. A 1990 update. , 1991, Ophthalmology.

[24]  G. Schmid-Schönbein,et al.  Perspectives of leukocyte activation in the microcirculation. , 1990, Biorheology.

[25]  A. Garner.  Histopathology of diabetic retinopathy in man , 1993, Eye.

[26]  E. Voest,et al.  Elevated ocular levels of vascular endothelial growth factor in patients with von Hippel-Lindau disease. , 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  T. Skalak,et al.  Leukocyte-capillary plugging and network resistance are increased in skeletal muscle of rats with streptozotocin-induced hyperglycemia. , 1994, International journal of microcirculation, clinical and experimental.

[28]  H. Little.  Alterations in blood elements in the pathogenesis of diabetic retinopathy. , 1981, Ophthalmology.

[29]  M. Bottomley,et al.  Activated human neutrophils express vascular endothelial growth factor (VEGF). , 1998, Cytokine.